Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gancberg

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Human Gene Therapy|July 1, 2017
Twenty Years of European Union Support to Gene Therapy and Gene TransferDavid Gancberg
Oncology Research|May 3, 2003
Oncoselective parvoviral vector-mediated gene therapy of cancerMarc Zeicher, Pierre Spegelaere, Marie Horth, et al.
Clinical Chemistry|February 24, 2009
European external quality control study on the competence of laboratories to recognize rare sequence variants resulting in unusual genotyping resultsJános Márki-Zay, Christoph L Klein, David Gancberg, et al.
Clinical Chemistry and Laboratory Medicine|February 27, 2008
Certification of reference materials for detection of the human prothrombin gene G20210A sequence variantDavid Gancberg, Philippe Corbisier, Nele Meeus, et al.
Analytical and Bioanalytical Chemistry|August 11, 2005
Quantitative determination of Roundup Ready soybean (Glycine max) extracted from highly processed flourPhilippe Corbisier, Stefanie Trapmann, David Gancberg, et al.
Clinical Chemistry and Laboratory Medicine|October 26, 2010
Nucleic acid reference materials (NARMs): definitions and issuesDeborah A Payne, Cyril D S Mamotte, David Gancberg, et al.
Breast Cancer Research and Treatment|August 21, 2002
Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testingDavid Gancberg, Tero Järvinen, Angelo di Leo, et al.
Clinical Chemistry and Laboratory Medicine|October 13, 2009
Considerations for the development of a reference method for sequencing of haploid DNA--an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics, International Federation of Clinical Chemistry and Laboratory MedicineFrançois Rousseau, David Gancberg, Heinz Schimmel, et al.
Anticancer Research|August 15, 2002
HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practiceDenis Larsimont, Angelo Di Leo, Ghizlane Rouas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracilAngelo Di Leo, David Gancberg, Denis Larsimont, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Human Gene Therapy|July 1, 2017
Twenty Years of European Union Support to Gene Therapy and Gene TransferDavid Gancberg
Oncology Research|May 3, 2003
Oncoselective parvoviral vector-mediated gene therapy of cancerMarc Zeicher, Pierre Spegelaere, Marie Horth, et al.
Clinical Chemistry|February 24, 2009
European external quality control study on the competence of laboratories to recognize rare sequence variants resulting in unusual genotyping resultsJános Márki-Zay, Christoph L Klein, David Gancberg, et al.
Clinical Chemistry and Laboratory Medicine|February 27, 2008
Certification of reference materials for detection of the human prothrombin gene G20210A sequence variantDavid Gancberg, Philippe Corbisier, Nele Meeus, et al.
Analytical and Bioanalytical Chemistry|August 11, 2005
Quantitative determination of Roundup Ready soybean (Glycine max) extracted from highly processed flourPhilippe Corbisier, Stefanie Trapmann, David Gancberg, et al.
Clinical Chemistry and Laboratory Medicine|October 26, 2010
Nucleic acid reference materials (NARMs): definitions and issuesDeborah A Payne, Cyril D S Mamotte, David Gancberg, et al.
Breast Cancer Research and Treatment|August 21, 2002
Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testingDavid Gancberg, Tero Järvinen, Angelo di Leo, et al.
Clinical Chemistry and Laboratory Medicine|October 13, 2009
Considerations for the development of a reference method for sequencing of haploid DNA--an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics, International Federation of Clinical Chemistry and Laboratory MedicineFrançois Rousseau, David Gancberg, Heinz Schimmel, et al.
Anticancer Research|August 15, 2002
HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practiceDenis Larsimont, Angelo Di Leo, Ghizlane Rouas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracilAngelo Di Leo, David Gancberg, Denis Larsimont, et al.
Pageof 2